drugset / Trial / NCT00901498
Relative Bioavailability Study of Four Experimental Formulations for Alzheimer's Disease
RandomizedCrossoverOpen-label
Summary
The purpose of this study is to assess the bioavailability of four experimental formulations relative to the current reference formulation used in the Phase 2 study.
Timeline
- Start
- 2009-05
- Primary completion
- 2009-07
- Completion
- 2009-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Avagacestat | Small molecule | 150 mg | Oral |